je.st
news
GSK in $350 million deal to develop cancer drugs with UK biotech firm - FT
2014-06-02 06:25:29| Biotech - Topix.net
GlaxoSmithKline Plc has agreed a deal worth more than $350 million with UK biotech company Adaptimmune to develop cancer drugs, the Financial Times reported on Monday.
Tags: million
deal
firm
develop
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||